Kristina Schnitzer1, Corrine Cather1, Anne N Thorndike1, Kevin Potter1, Oliver Freudenreich1, Sarah MacLaurin1, Mike Vilme1, Alyson Dechert1, Deborah Wexler1, Anne Eden Evins1. 1. Center for Addiction Medicine, Department of Psychiatry (Schnitzer, Cather, Vilme, Dechert, Evins), Schizophrenia Research Program (Schnitzer, Cather, Freudenreich, MacLaurin, Vilme, Dechert, Evins), Diabetes Center, Department of Medicine (Wexler) and General Medicine Division, Department of Medicine (Thorndike), Department of Biostatistics (Potter), all at Massachusetts General Hospital (MGH), Boston; Erich Lindemann Mental Health Center, Freedom Trail Clinic, Boston (Freudenreich, MacLaurin).
Abstract
OBJECTIVE: The purpose of this study was to evaluate a 16-week, reverse-integrated care (bringing primary care interventions/services into the psychiatric setting) behavioral and educational group intervention for individuals with serious mental illness and diabetes. METHODS: The primary outcome was change in glycated hemoglobin (HbA1c). Secondary outcomes included body mass index (BMI), blood pressure, lipid levels, physical activity, diabetes knowledge, and self-care. RESULTS:Thirty-five participants attended at least one group and were included in a modified intent-to-treat analysis. From baseline to week 16, HbA1c improved, from 7.5±1.6 to 7.1±1.4, p=0.01, and BMI improved, from 33.3±3.8 to 32.9±4.1, p<0.001, as did measures of diabetes knowledge and self-care. One-year follow-up in a subset of participants showed no evidence of rebound in HbA1c. CONCLUSIONS: This 16-week behavioral and educational group intervention resulted in improvements in glycemic control, BMI, diabetes knowledge, and self-care. The results warrant larger-scale, controlled trial testing of this intervention to improve diabetes-related health outcomes in those with serious mental illness.
RCT Entities:
OBJECTIVE: The purpose of this study was to evaluate a 16-week, reverse-integrated care (bringing primary care interventions/services into the psychiatric setting) behavioral and educational group intervention for individuals with serious mental illness and diabetes. METHODS: The primary outcome was change in glycated hemoglobin (HbA1c). Secondary outcomes included body mass index (BMI), blood pressure, lipid levels, physical activity, diabetes knowledge, and self-care. RESULTS: Thirty-five participants attended at least one group and were included in a modified intent-to-treat analysis. From baseline to week 16, HbA1c improved, from 7.5±1.6 to 7.1±1.4, p=0.01, and BMI improved, from 33.3±3.8 to 32.9±4.1, p<0.001, as did measures of diabetes knowledge and self-care. One-year follow-up in a subset of participants showed no evidence of rebound in HbA1c. CONCLUSIONS: This 16-week behavioral and educational group intervention resulted in improvements in glycemic control, BMI, diabetes knowledge, and self-care. The results warrant larger-scale, controlled trial testing of this intervention to improve diabetes-related health outcomes in those with serious mental illness.
Entities:
Keywords:
medical morbidity; mortality in psychiatric patients; schizophrenia
Authors: Anna Dossing; Simon Tarp; Daniel E Furst; Christian Gluud; George A Wells; Joseph Beyene; Bjarke B Hansen; Henning Bliddal; Robin Christensen Journal: J Clin Epidemiol Date: 2015-11-10 Impact factor: 6.437
Authors: Martha Sajatovic; Douglas D Gunzler; Stephanie W Kanuch; Kristin A Cassidy; Curtis Tatsuoka; Richard McCormick; Carol E Blixen; Adam T Perzynski; Douglas Einstadter; Charles L Thomas; Mary E Lawless; Siobhan Martin; Corinna Falck-Ytter; Eileen L Seeholzer; Christine L McKibben; Mark S Bauer; Neal V Dawson Journal: Psychiatr Serv Date: 2017-05-15 Impact factor: 3.084
Authors: Christine L McKibbin; Thomas L Patterson; Gregory Norman; Kevin Patrick; Hua Jin; Scott Roesch; Sunder Mudaliar; Concepcion Barrio; Kathleen O'Hanlon; Kay Griver; A'verria Sirkin; Dilip V Jeste Journal: Schizophr Res Date: 2006-07-12 Impact factor: 4.939
Authors: Siobhan Reilly; Ivan Olier; Claire Planner; Tim Doran; David Reeves; Darren M Ashcroft; Linda Gask; Evangelos Kontopantelis Journal: BMJ Open Date: 2015-12-15 Impact factor: 2.692